The Board of Directors of Sunshine Holdings PLCd appointed Sanjeev Shishoo, formerly the corporate Vice President of global healthcare giant, Novo Nordisk’s Global Service Centre (GSC) in Bangalore, as a Director of the Company. The appointment is effective January 1, 2018. With the new appointment, the Board of Sunshine Holdings PLC will now be comprised of 11 Directors of which seven are non-executive, independent directors.
A qualified healthcare management professional, Sanjeev Shishoo, counts over 25 years with Novo Nordisk, previously as Vice President, Business Area Oceania & South East Asia, based in Kuala Lumpur, Vice President, Regional Office Far East based in Bangalore and the Vice President of the Regional Office in India. Novo Nordisk, a global healthcare company counts more than 90 years of innovation and leadership in diabetes care. Headquartered in Denmark, Novo Nordisk employs approximately 41,700 people in 77 countries and markets its products in more than 165 countries.
“We are delighted to welcome Sanjeev to Sunshine’s Board of Directors,” said Vish Govindasamy, Group Managing Director, Sunshine Holdings PLC. “His exceptional knowledge of the healthcare and pharmaceutical industry and trends combined with deep business experience will be of tremendous benefit to our Company.”
Shishoo holds a Bachelor’s and Master’s degree in Pharmacology and a MBA from the Indian Institute of Management (IIM) – Calcutta, a leading Business School in India and has a track record of creating high performing teams that deliver ambitious targets and is skilled in marketing strategy & implementation. Building healthcare brands has been his passion and was responsible for making Novo Nordisk’s insulin, Mixtard, the Number 1 Pharma brand in India.
The Board of Directors of Sunshine Holdings PLC comprises M. Shaikh, G. Sathasivam, V. Govindasamy, N.B. Weerasekara, B.A. Hulangamuwa, S.G Sathasivam, H.D. Abeywickrama, A. Talwatte, R. Kobbekaduwa and A. Cabraal.
About Sunshine Holdings PLC: Sunshine Holdings PLC is a diversified conglomerate with interests in Healthcare, Plantations, FMCG, Packaging and Renewable Energy. The Group with revenue exceeding US $120 million is listed on the Colombo Stock Exchange. Beginning with the healthcare business in 1967, the group has built strong businesses over the last five decades, including partnering with the Tata Group in 1992 to form a joint venture in Plantations. Group companies include Sunshine Healthcare Lanka, Watawala Plantations PLC, Watawala Tea Ceylon Ltd, and Sunshine Energy.
Photo caption: Sanjeev Shishoo
↧